Ginkgo Bioworks Holdings, Inc. — Director's Dealing 2022

Oct 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Ginkgo Bioworks Holdings, Inc. (DNA)
CIK: 0001830214
Period of Report: 2022-10-26

Reporting Person: Canton Barry (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-26	Class A Common Stock	S	189138	$2.904	Disposed	23578070	Direct
2022-10-26	Class A Common Stock	S	189138	$2.904	Disposed	23578068	Indirect
2022-10-27	Class A Common Stock	S	204478	$2.706	Disposed	23373592	Direct
2022-10-27	Class A Common Stock	S	204477	$2.706	Disposed	23373591	Indirect

Footnotes

F1: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction.